Overview

Adalimumab Plus Methotrexate for the Treatment of Pediatric Uveitis

Status:
Recruiting
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the efficacy and safety of ADA plus MTX for the treatment in non-infectious pediatric panuveitis.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Adalimumab
Methotrexate